首页 正文

Biologics for cardiovascular diseases: from bench to bedside

{{output}}
The rise of biologics, including recombinant proteins, gene therapies, and cell therapies, is reshaping the landscape of modern therapeutics, offering new strategies to address previously "undruggable" targets. Cardiovascular diseases (CVDs), the leading cau... ...